US Patent Issued to EUREKA THERAPEUTICS on Nov. 25 for "Constructs specifically recognizing Glypican 3 and uses thereof" (California Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,479,924, issued on Nov. 25, was assigned to EUREKA THERAPEUTICS INC. (Emeryville, Calif.).

"Constructs specifically recognizing Glypican 3 and uses thereof" was invented by Pengbo Zhang (Fremont, Calif.), Yiyang Xu (Pleasanton, Calif.), Javier Morales (San Jose, Calif.), Yoko Nakano (El Cerrito, Calif.), Hong Liu (El Sobrante, Calif.), Jingyi Xiang (Walnut Creek, Calif.) and Timothy Acker (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application provides constructs comprising an antibody moiety specifically recognizing Glypican 3 (GPC3), such as a cell surface-bound GPC3. Also provided are methods of making and using these co...